RecruitingNot ApplicableNCT06640205

Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars

Clinical and Radiographic Assessment of I-PRF Versus Nano Mineral Trioxide Aggregate Combined with I-PRF Scaffold in Vital Pulp Therapy in Mandibular First Molars with Closed Apices: "Randomized Controlled Trial"


Sponsor

Future University in Egypt

Enrollment

51 participants

Start Date

Sep 3, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Assessment of I-PRF versus Nano Mineral trioxide aggregate Combined with I-PRF in pulpotomy in mature Mandibular First Molars


Eligibility

Min Age: 15 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called pulpotomy for people with pulpotomy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 15 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREpulpotomy

Removal of coronal pulp tissue and then placing pulpotomy agent


Locations(1)

Future university in egypt

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06640205


Related Trials